[ad_1]
We named former Board Chairman Dr. Doug Garr a Distinguished Fellow in recognition of his dedication and leadership during a special time in our history.
The Distinguished Fellow role is a lifetime appointment that honors those who have made exceptional contributions to our mission through volunteerism or support of philanthropy. Dr. Garr will step down from the Board of Directors after seven years in October 2022 and is currently Director of the Natural History Museum and Director of the Alan Turing Institute. During his time as Chair, he guided us through the COVID-19 pandemic, sustaining research and ensuring we were there for people when they needed it most. It is through his leadership that our commitment to life-saving research has never wavered, even during these difficult times.
A key role in shaping and driving our strategy
As Chair, Dr Garr also oversaw the implementation of some of our biggest scientific initiatives, including the £30m Big Beat Challenge and the launch of our Data Science Centre. Passionate about the power of his research, Dr. Garr has used his expertise to support philanthropic causes that raise vital funds. His personal support for our Cardiovascular Catalyst Award has helped drive innovative projects that have a measurable impact on patients.
Through his generous contributions to key initiatives, he played a key role in developing and driving our 2030 strategy.
raised our ambitions
Congratulating Dr Garr, Chief Executive Dr Charmaine Griffiths said:
As our Chairman, his vision has undoubtedly elevated our ambitions and his leadership on the Board has been critical in guiding us through the most challenging period in our 62-year history. On behalf of our team and the countless people we interact with every day, we sincerely thank Doug for his leadership and his continued support as part of our family.
“It’s a privilege.”
Dr. Garr says: “I am honored to have been appointed as a Fellow and to continue my involvement with such a pioneering organization. The importance of our work is clear, from harnessing the potential of artificial intelligence to transform the lives of all.
I am proud of everything we accomplished during my time as Chair and continue to be inspired by our supporters, researchers, and heart disease community. I look forward to continuing to contribute as an excellent fellow. ”
“The best cardiovascular research”
Dr Sarah Clarke, our Vice Chair, said: His pivotal role in supporting our philanthropic efforts by showcasing and championing our work ensures that we continue to fund the best cardiovascular research. It’s done. ”
Learn more about our researchers
[ad_2]
Source link